A 64-year-old retiree with $475,000 who wants to generate $2,800 per month, or $33,600 annually, from dividends alone needs a portfolio yield of roughly 7%. That is simply the arithmetic. With the S&P 500 yielding well under 2%, a traditional index-fund portfolio falls far short of producing that level of income without selling shares. The ... A $475,000 Portfolio That Quietly Pays $2,800 a Month ...
A 64-year-old retiree with $475,000 who wants to generate $2,800 per month, or $33,600 annually, from dividends alone needs a portfolio yield of roughly 7%. That is simply the arithmetic. With the S&P 500 yielding well under 2%, a traditional index-fund portfolio falls far short of producing that level of income without selling shares. The ... A $475,000 Portfolio That Quietly Pays $2,800 a Month From Just Two Sectors Most Investors Ignore
Meta Begins 8,000 Global Job Cuts in AI Efficiency Push Bloomberg.com Meta begins 8,000 job cuts in AI efficiency push Los Angeles Times Exclusive: Meta CEO tells employees he does not expect more company-wide layoffs this year Reuters Meta begins cutting thousands of jobs amid AI push Austin American-Statesman Meta shifts 7,000 workers into AI roles as layoffs, manager cuts loom Fox Business Meta...
Meta Begins 8,000 Global Job Cuts in AI Efficiency Push Bloomberg.com Meta begins 8,000 job cuts in AI efficiency push Los Angeles Times Exclusive: Meta CEO tells employees he does not expect more company-wide layoffs this year Reuters Meta begins cutting thousands of jobs amid AI push Austin American-Statesman Meta shifts 7,000 workers into AI roles as layoffs, manager cuts loom Fox Business Meta layoffs starting this week stress harsh AI reality inside Zuckerberg’s company CNBC Meta Platforms begins new round of layoffs affecting ~8,000 employees Seeking Alpha Meta layoffs: 4am email ‘horror’ starts from … The Times of India Meta Platforms Restructures Workforce To Prioritize AI And Test Valuation Gap Yahoo Finance
Key Points CVS surprised analysts with improved revenue and earnings in the first quarter. The company is seeing a rebound from its health care benefits segment. It is also seeing a surge in sales related to its Rite Aid acquisitions. 10 stocks we like better than CVS Health › CVS Health (NYSE: CVS) may just have the prescription for your investing needs if you're looking for long-term growth. The...
Key Points CVS surprised analysts with improved revenue and earnings in the first quarter. The company is seeing a rebound from its health care benefits segment. It is also seeing a surge in sales related to its Rite Aid acquisitions. 10 stocks we like better than CVS Health › CVS Health (NYSE: CVS) may just have the prescription for your investing needs if you're looking for long-term growth. The shares of the nation's largest pharmacy chain had been overlooked until recently, because of the company's thin margins and relatively slow growth. However, over the past month, CVS stock has risen by around 24%. That's thanks to a strong first-quarter earnings report, a turnaround in its worst-performing segment, and subsequent analyst upgrades. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Here are three reasons why the rally for this healthcare company may have some legs, and one reason to still be cautious. Earnings and guidance have improved In the first quarter, reported revenue jumped 6.2% year over year to $100.4 billion, while earnings per share (EPS) were $2.30, up 62% over the same period a year ago. Both numbers surprised analysts, who had predicted revenue of $94.4 billion and EPS of $1.93. The upbeat report led the company to raise its full-year guidance. EPS is now predicted to be between $6.24 and $6.44, up 4.9% at the midpoint, and adjusted EPS is expected to be between $7.30 and $7.50, up 4.2% at the midpoint. The company also said it now expects cash flow from operations to be at least $9.5 billion, up from $9 billion. The dividend yield is still quite attractive CVS offers a dividend, at its current share price, of around 2.8%, more than double the average dividend of the S&P 500. The company's consistently high free cash flow allows it to maintain its payouts. In recent fiscal year...
The world’s top players are planning to protest over prize money by reducing their media appearances at the French Open as their public battle with the grand slams intensifies. Players selected to take part in Friday’s opening press conference at Roland Garros will walk out after 15 minutes, symbolising that the slams allocate an average of 15% of their revenues to prize money. The rest of the dra...
The world’s top players are planning to protest over prize money by reducing their media appearances at the French Open as their public battle with the grand slams intensifies. Players selected to take part in Friday’s opening press conference at Roland Garros will walk out after 15 minutes, symbolising that the slams allocate an average of 15% of their revenues to prize money. The rest of the draw will refuse to conduct additional interviews with the tournament’s main media rights partners, TNT Sports and Eurosport. A source close to the players said that after the French Open confirmed this month this year’s prize pot will be €61.7m (£52.6m), locker room talks have led them to respond with what they described as a “work to rule strategy” in Paris, with their off-court activities to be kept to a bare minimum. The players are understood to have studied the tournament rulebook and concluded they will not be fined as long as they fulfil their contractual obligations to conduct a short flash interview with rights holders after each match. The leading 20 male and female players, including Novak Djokovic, Jannik Sinner, Aryna Sabalenka and Coco Gauff, have been in dispute with all four grand slams for more than a year. They feel they are given an insufficient share of each tournament’s increasing revenues, while they have also demanded enhanced welfare and pension provisions and a greater say in determining tournament schedules. After the French Open’s prize money announcement, Sabalenka and Gauff raised the prospect of players boycotting the grand slams during interviews conducted at the Italian Open in Rome, although Iga Swiatek and Emma Raducanu distanced themselves from talk of a strike. The French Open prize fund has risen by 9.5% this year, with the men’s and women’s winners to receive €2.8m, but the players are unhappy the increase is far more modest as a percentage of tournament revenues. While Roland Garros’s income increased by 14% to €395m last year, prize mon...
(RTTNews) - HUMAIN, an AI company, and Accenture plc (ACN), the IT and consulting giant, Wednesday announced that they are collaborating to accelerate the adoption of AI across government entities and enterprises in Saudi Arabia. Accenture will be a strategic reinvention & AI partner in Saudi Arabia, helping HUMAIN scale its AI capabilities across the Kingdom, the companies said in a statement. HU...
(RTTNews) - HUMAIN, an AI company, and Accenture plc (ACN), the IT and consulting giant, Wednesday announced that they are collaborating to accelerate the adoption of AI across government entities and enterprises in Saudi Arabia. Accenture will be a strategic reinvention & AI partner in Saudi Arabia, helping HUMAIN scale its AI capabilities across the Kingdom, the companies said in a statement. HUMAIN will bring full AI stack including next-generation data centers, high-performance infrastructure and cloud platforms, advanced AI models, and applied AI solutions along with Accenture's capability to design, build, and run AI-driven transformation. Together, the companies will focus on AI Reinvention Services, Enterprise AI Architecture, Workforce Transformation, Ecosystem Activation, and Digital Trust. In pre-market activity, ACN shares were trading at $176.05, down 0.40% on the New York Stock Exchange. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
the_guitar_mann/iStock Editorial via Getty Images Shares of Boeing ( BA ) were little changed Wednesday morning after China’s Commerce Ministry confirmed plans to purchase 200 Boeing aircraft, along with engines and spare parts, in the first major Chinese order for the U.S. planemaker since 2017. The announcement highlights a possible easing in commercial tensions between Washington and Beijing, w...
the_guitar_mann/iStock Editorial via Getty Images Shares of Boeing ( BA ) were little changed Wednesday morning after China’s Commerce Ministry confirmed plans to purchase 200 Boeing aircraft, along with engines and spare parts, in the first major Chinese order for the U.S. planemaker since 2017. The announcement highlights a possible easing in commercial tensions between Washington and Beijing, while underscoring Boeing’s ( BA ) importance to the global aviation supply chain despite years of production disruptions and geopolitical friction. Boeing ( BA ) reported a commercial aircraft backlog of 6,814 orders as of April 30 and delivered 190 commercial airplanes through the first four months of the year, giving investors a clearer picture of the company’s production momentum and future revenue pipeline. “In accordance with the important consensus reached by the Chinese and U.S. leaders, China’s aviation industry will introduce 200 Boeing aircraft based on commercial principles and its own needs for air transport development,” a Commerce Ministry official said in a statement Wednesday. President Donald Trump told Fox News last week that China would buy 200 Boeing ( BA ) jets. Although analysts had expected a larger agreement, the deal still represents a significant reopening of the Chinese market for Boeing ( BA ) after years of strained relations tied to trade disputes and safety concerns surrounding the 737 Max. For investors, the order signals renewed access to one of the world’s most important aviation markets at a time when Boeing ( BA ) is attempting to ramp up production and stabilize deliveries. The company’s large order backlog already provides years of manufacturing demand, but fresh Chinese business could improve long-term visibility into cash flow while supporting thousands of aerospace suppliers across the United States. Andrea Chartock, assistant director of the Office of Economic Development and Competitiveness at the Washington State Department of Com...
Stellantis ( STLA ) and Jaguar Land Rover inked a memorandum of understanding to explore opportunities to collaborate on product development in the U.S. Under the terms of the non-binding MOU, Stellantis ( STLA ) and Jaguar Land Rover will explore collaboration opportunities to create synergies across product and technology development, leveraging the companies’ complementary strengths to create v...
Stellantis ( STLA ) and Jaguar Land Rover inked a memorandum of understanding to explore opportunities to collaborate on product development in the U.S. Under the terms of the non-binding MOU, Stellantis ( STLA ) and Jaguar Land Rover will explore collaboration opportunities to create synergies across product and technology development, leveraging the companies’ complementary strengths to create value for both organizations. "By working with partners to explore synergies in areas such as product and technology development, we can create meaningful benefits for both sides while remaining focused on delivering the products and experiences our customers love," highlighted Stellantis ( STLA ) CEO Antonio Filosa. The automakers noted that implementation of any potential transactions as a result of the MOU discussions would be subject to customary closing conditions, including execution of binding definitive agreements. Jaguar Land Rover is a British carmaker that has been a wholly owned subsidiary of India's Tata Motors since 2008. Tata Motors created Jaguar Land Rover Limited as the holding company to acquire the separate Jaguar and Land Rover businesses from Ford Motor Company ( F ) that year. Shares of Stellantis ( STLA ) moved 1.4% higher in premarket trading on Wednesday. More on Stellantis Stellantis: A EUR130M Bet To Rebuild After A EUR22B Wreck (Rating Upgrade) Stellantis N.V. (STLA) Q1 2026 Earnings Call Transcript Stellantis N.V. 2026 Q1 - Results - Earnings Call Presentation Stellantis, Dongfeng partner to form European joint venture for EVs Stellantis unveils affordable small EV project, targets 2028 production start in Italy
primeimages/E+ via Getty Images Investor sentiment thrived in April even in the wake of an erratic geopolitical backdrop that has stoked fears of stagflation. Markets were whipsawed as investors digested a plethora of headlines around the Middle East conflict that has reshaped the outlook for energy prices, inflation, and growth. However, optimism around the artificial intelligence (AI) trade and ...
primeimages/E+ via Getty Images Investor sentiment thrived in April even in the wake of an erratic geopolitical backdrop that has stoked fears of stagflation. Markets were whipsawed as investors digested a plethora of headlines around the Middle East conflict that has reshaped the outlook for energy prices, inflation, and growth. However, optimism around the artificial intelligence (AI) trade and a wave of upbeat earnings results in the megacap tech space drove stock markets to record highs. Still, the prolonged closure of the Strait of Hormuz has upended global energy flows and ushered in an energy crisis that has stoked fears about demand destruction and a hit to global growth. Source: Bloomberg, as of April 30, 2026. Global equity markets (+10.0%) soared higher in April. The S&P 500 (+10.4%) capped its best monthly return since November 2020. However, gains were narrow – with the so-called Magnificent 7 group of stocks (+14.9%) driving much of the gain – while the equal-weighted index was up just 5.9%. The S&P/TSX (+3.6%) underperformed amid relatively subdued returns in the heavyweight gold (-6.0%) and energy (+1.9%) sectors. That offset a respectable gain in the financials (+10.1%) space. Elsewhere, the MSCI EAFE (+7.0%) had a decent month, while the MSCI gauge of emerging market stocks (+14.5%) led the global charge – powered higher by a rally in Asian chipmaker stocks. Fixed income markets barely budged. Global bond yields pushed higher following a wave of hawkish-leaning rhetoric from central banks. Indeed, persistent Middle East tensions and the blockade of the critical waterway spurred a rally in oil prices that has exacerbated inflation fears. Traders recalibrated their expectations for monetary policy in response and have all but abandoned their wagers for Federal Reserve rate cuts this year and have begun pricing in the chances of a rate hike in 2027 – while markets are currently pricing-in over two rate hikes from the Bank of Canada by year-end. For th...
AMD Chief Executive Lisa Su praised the openness and dynamism of China’s AI ecosystem at the company’s AI Developer Day in Shanghai on May 19. Advanced Micro Devices Inc. CEO Lisa Su highlighted the rapid rise of agentic AI and the critical need for on-device computing power during a Tuesday developer event in Shanghai. Su praised the vitality of China’s artificial intelligence ecosystem, predicti...
AMD Chief Executive Lisa Su praised the openness and dynamism of China’s AI ecosystem at the company’s AI Developer Day in Shanghai on May 19. Advanced Micro Devices Inc. CEO Lisa Su highlighted the rapid rise of agentic AI and the critical need for on-device computing power during a Tuesday developer event in Shanghai. Su praised the vitality of China’s artificial intelligence ecosystem, predicting that the global active AI user base will reach 5 billion in the coming years. This industry pivot toward edge computing reflects an intensifying battle among chipmakers to dominate the emerging AI PC market, as data privacy concerns and cloud costs drive developers to process complex, multi-agent workloads directly on personal hardware.
Cognyte Software ( CGNT ) announced on Wednesday a ~$5M upgrade deal with a long-time national security agency customer in the APAC region. The upgrade will enhance its investigative analytics system with newer AI tools for faster and more efficient investigations. The deal comes as security agencies face rising data and more complex threats, increasing demand for advanced analytics solutions. CGN...
Cognyte Software ( CGNT ) announced on Wednesday a ~$5M upgrade deal with a long-time national security agency customer in the APAC region. The upgrade will enhance its investigative analytics system with newer AI tools for faster and more efficient investigations. The deal comes as security agencies face rising data and more complex threats, increasing demand for advanced analytics solutions. CGNT said that follow-on deals with existing customers remain a key growth driver and support its long-term revenue outlook. The stock is trading ~2% lower at ~$9.80 in premarket trading hours. Source: Press Release More on Cognyte Software Cognyte Software: Compelling EBITDA, Low Dilution Cognyte Software Ltd. 2026 Q4 - Results - Earnings Call Presentation Cognyte Software Ltd. (CGNT) Q4 2026 Earnings Call Transcript Cognyte enters three-year subscription agreement worth over $20M with EMEA customer Cognyte jumps 15% on U.S. law enforcement contract win, expands North America footprint
Optimi Health ( OPTHD ) announced on Wednesday the pricing of its underwritten public offering in connection with the uplisting of its common shares to Nasdaq. The company is offering 2.4M common shares at a public offering price of $6.25 per share. It has also granted the underwriter the option to purchase up to an additional 360,000 common shares. The common shares are expected to begin trading ...
Optimi Health ( OPTHD ) announced on Wednesday the pricing of its underwritten public offering in connection with the uplisting of its common shares to Nasdaq. The company is offering 2.4M common shares at a public offering price of $6.25 per share. It has also granted the underwriter the option to purchase up to an additional 360,000 common shares. The common shares are expected to begin trading on Nasdaq on May 20, 2026, under the symbol "OPTH." Optimi Health highlighted that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the company, are expected to be approximately $15 million, excluding any exercise of the underwriter's option to purchase additional shares. The offering is expected to close on or about May 21, 2026. The company intends to use the net proceeds for scaling production and distribution of its products in its current markets, additional market expansion, including the United States , and sales growth and general working capital and other operating expenses. Joseph Gunnar & Co. is acting as sole book-running manager for the offering. More on Optimi Health Corp. Financial information for Optimi Health Corp.
SlavkoSereda/iStock via Getty Images Model Allocation Update (May 2026) This article provides ongoing analysis of my Asset Allocation Model (the " Model Allocation " or " Model "). Per usual, this update will analyze the performance of certain investment ideas generated for the Model Allocation's portfolio for 2026 (the " Model Portfolio " or " Portfolio "). Below are the current asset allocations...
SlavkoSereda/iStock via Getty Images Model Allocation Update (May 2026) This article provides ongoing analysis of my Asset Allocation Model (the " Model Allocation " or " Model "). Per usual, this update will analyze the performance of certain investment ideas generated for the Model Allocation's portfolio for 2026 (the " Model Portfolio " or " Portfolio "). Below are the current asset allocations of the Model compared to where they stood on March 6, 2026. Current Model Allocations As of May 18, 2026, the updated allocations for the eight (8) asset allocation buckets constituting the current Model Portfolio are as follows. Asset Class Target Allocation % % As of May 18, 2026 % As of March 6, 2026 Inflation Beneficiary Equities (" IBEs ") 15-20 16 15 BTC & Blockchain Equities 1-5 2 2 Growth Stocks 15-20 16 14 Quality Stocks 20-25 22 23 Speculative Investments 5-10 8 8 Precious Metals 5-10 7 10 All-Weather ETFs 5-10 10 8 Cash/Cash Equivalents 5-20 19 20 Click to enlarge Market Direction Unknown; Inflation Up & Away My March Portfolio Update showed me getting more defensive and shorting the Nasdaq which proved timely at least for the next three-and-a-half weeks thereafter. Then, starting about March 31, 2026, the Invesco QQQ Trust, Series 1 ETF ( QQQ ) proceeded to rally aggressively through the end of April as shown below. Seeking Alpha Finding myself off-sides, I capitulated and closed out my short position on April 6th and began putting some cash to work, reducing the Cash & Cash Equivalents allocation by 100 basis points (from 20% to 19%). Specifically, cash plus short close-out proceeds were used to increase my Growth Bucket allocation, which had been hovering below its 15% minimum target allocation, increasing the bucket from 14% to 16%. Notably, I have added a starter position in the Grizzle Growth ETF ( DARP ). The BTC & Blockchain Equities bucket stayed steady, even though underneath the hood there was a lot of volatility, as well as trading around core positi...
Caleres ( CAL ) has appointed Dan Karpel as senior vice president and chief financial officer, effective immediately. Karpel rejoined Caleres as chief accounting officer in October 2025 and was appointed to the role of interim chief financial officer in January 2026. He will serve as the company's principal financial officer and principal accounting officer. CAL shares were up +3.4% premarket. Mor...
Caleres ( CAL ) has appointed Dan Karpel as senior vice president and chief financial officer, effective immediately. Karpel rejoined Caleres as chief accounting officer in October 2025 and was appointed to the role of interim chief financial officer in January 2026. He will serve as the company's principal financial officer and principal accounting officer. CAL shares were up +3.4% premarket. More on Caleres Caleres, Inc. (CAL) Q4 2025 Earnings Call Transcript Caleres Is Now Reasonably Priced, But Is Not Attractive After The Rally Caleres, Inc. 2025 Q4 - Results - Earnings Call Presentation Caleres Non-GAAP EPS of -$0.36 beats by $0.04, revenue of $695.1M beats by $9.68M Caleres FY 2026 Earnings Preview
designer491/iStock via Getty Images Personalis ( PSNL ) shares rose ~5% in the premarket on Wednesday after the company received the fourth Medicare decision, which will broaden coverage for its NeXT Personal minimal residual disease test in the U.S. In a press release, the cancer test maker said that the latest coverage determination by the Molecular Diagnostic Services Program of the U.S. Center...
designer491/iStock via Getty Images Personalis ( PSNL ) shares rose ~5% in the premarket on Wednesday after the company received the fourth Medicare decision, which will broaden coverage for its NeXT Personal minimal residual disease test in the U.S. In a press release, the cancer test maker said that the latest coverage determination by the Molecular Diagnostic Services Program of the U.S. Centers for Medicare & Medicaid Services will broaden NeXT Personal’s clinical use in breast cancer. According to the company, the MolDX decision will enable Medicare beneficiaries with stage II and III triple-negative breast cancer or HER2-positive breast cancer to receive reimbursement for NeXT Personal's use in monitoring treatment response to their neoadjuvant therapy. The decision marks a coverage expansion for the test following a determination by Medicare in November to cover NeXT Personal for recurrence monitoring after surgery in patients with stage II and III breast cancer. More on Personalis Personalis, Inc. (PSNL) Q1 2026 Earnings Call Transcript Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript Personalis rises as Medicare coverage for NeXT Personal test expands Personalis outlines 2026 clinical volume target of 43,000 to 45,000 tests while reaffirming $78M to $80M revenue guidance Seeking Alpha’s Quant Rating on Personalis